Our team

Watch: Believing in each other

Abdi Moazami

Senior Director, Compliance

Alan Chen

Research Associate

Alex Ewing

Principal, Data Strategy

Alice Lee, JD

Senior Counsel

Anisha Soni

Senior Associate, Client Service & Investor Relations

Annabelle Chan

Social Media Manager

Anthony Williams

Director of Tax, Family Office

Cade Himmel

Operations Associate

Cesar Benjumea

Research Specialist

Charles Anyamene

Vice President, Emerging Business Opportunities

Chris Liu, PhD

Senior Research Analyst

Chris Seiter

Chief Corporate Finance Officer, Co-Head of RTW Royalty Funds

Christina Mastrangelo

Executive Assistant, RTW Foundation

Christine Murren, SHRM-CP

HR Generalist

Christopher Krone, CPA

Director of Finance, Family Office

Connor Williams

Senior Research Analyst

Da Xu

Policy Analyst

Daniel (DJ) Wendler, MD

Vice President, Royalty

Danielle Petras

Executive Assistant to the Managing Partner

Dar Patel, JD

General Counsel & CCO

David Pan

Head of Family Office

Devon Taylor Leaver

Senior Associate, Brand Experience

Elizabeth Drelichman

Policy Analyst

Elizabeth McAdams

Director of Strategy and Operations, Family Office

Gabrielle Gioscia

Executive Assistant

Gotham Makker, MD

Partner, Head of Strategic Investments

Hannah Berkowitz

Associate, Family Office

Ilke Roelofse, PhD

Research Specialist

Irene Park

Research Analyst

Jamie Lynne Carlson

Senior Talent Acquisition Associate

Jennifer Laine Williams

Personal Assistant, Family Office

Jingqing Zhang, PhD

Research Analyst

Joe Katakowski Ph.D

Director, Rare Disease, RTW Foundation

John Maraganore, PhD

Executive Partner

John Wasilewski

Managing Director, Business Development

Joshua Kennedy-Smith, PhD

Partner, Research Analyst

Julia Harper

Senior Director and Head of Investor Relations

Kayla Jones

Receptionist

Kelly Scholtz

Marketing, IR Coordinator

Kieran McKeon

Valuations Associate

Kinnari Patel, PharmD, MBA

Chief Executive Officer

Krisha McCune

Director, Investor Relations, RTW Biotech Opportunities

Lauren Cuje

Managing Director, New Ventures

Lauren Lee, PhD

Research Analyst

Lina Tseng

Asset Selection Executive Assistant

Lindsay McBride

Corporate Access Manager & Broker Relations Liaison

Lorrie Herbert, CPA

Senior Director, Valuations

Luc Ghaleb

Associate

Luna Ji, MD

Principal

Mari Tikoyan

Research Coordinator

Michael Norman

Vice President, New Ventures

Marisa Merendeiro

Executive Assistant

Matt Lane, CPA

Senior Associate, Fund Accountant

Marti Speranza Wong

Co-Chair, RTW Foundation

Matthew Bieret, CPA

Managing Director, Finance

Michelle Krinke

Head Trader

Mike Christman

Managing Director, Operations

Musa Sukalic

Senior Associate, IT

Naveen Yalamanchi, MD

Partner, Portfolio Manager

Nehal Gosalia, PhD

Research Analyst, Director of Genetics

Nicole Litt

Program Manager, Rare Disease, RTW Foundation

Olivia Ringham PhD

Royalty Associate

Oliver Kenyon

Senior Director, Business & Corporate Development

Paiton Marshall

Corporate Finance Associate

Paula Boone, CPA

Global Management Company Controller

Paul Lu, PhD

Managing Director, Head of Corporate Development

Peter Fong, PhD

Partner, President

Piratip Pratumsuwan

Managing Director, Research Analyst

Rachel Schlosser, JD

Associate Counsel

Ram Modh

Research Analyst

Robert Aurigema

Partner, Chief Operating Officer and Chief Financial Officer

Robert Rapaport

Research Analyst

Roderick Wong, MD

Managing Partner, Chief Investment Officer

Ryan Sherman, CPA

Senior Director, Finance & Operations

Sabera Loughran

Partner Emeritus, Founding COO and CFO

Sabrina Xiao

Director, OMNI Research

Sam Na

Head of Valuations

Samantha Darris

Communications Manager, RTW Foundation

Samantha Larsen, PhD

Vice President, New Ventures

Sarah Garwood

Director, Community Engagement, RTW Foundation

Scott Band, CPA

Managing Director, Tax

Sean Haggerty

Managing Director

Simon Viergutz

Principal, EBO & Company Creation

Shalini Sinha

Managing Director, Head of Human Resources

Sharan Seloj

Paralegal

Sonia Mitchell

Director of Property Management, Family Office

Steve Raymundo

BioQuest Program Associate, RTW Foundation

Stephanie A. Sirota

Partner, Chief Business Officer

Stephanie Gajdjis

Associate, Investor Relations

Sweeny Pillot

Executive Assistant

Tera Kelley

Firm Services Executive Assistant

Teysha Popescu

Office Manager

Tony Nguyen

Partner, Research Analyst and Co-Head of RTW Royalty Funds

Varsha Prakash Kodiyan, PhD

Research Specialist

Vincent Liu, PhD

Research Associate

Vincent Masto, PhD

Research Associate

Woody Stileman

Managing Director, Business Development

Ying Wang

Managing Director, Business Development

YingYu Lin

Production Coordinator

Yuantao Li, PhD

Research Analyst

Zach Feller, CPA

Controller

Shalini Sinha

Head of Human Resources

People are core to the foundation of any company and we have a great group. We hire extraordinary people and we build extraordinary teams.

Nehal Gosalia, PhD

Research Analyst, Director of Genetics

My favorite part about RTW is that we’re really a collaborative team. What makes it fun for me is my core team discussing science and all of the problems and puzzles that we solve together every day.

Nehal Gosalia, PhD

This website is not intended to offer or to promote the offer or sale of the shares (the “Shares”) of RTW Biotech Opportunities Ltd (the “Company”) in the United States or to any “U.S. persons” as defined in Regulation S (“US persons”) under the US Securities Act of 1933, as amended (the “Securities Act”). The materials contained herein are not for release, publication or distribution, directly or indirectly, in whole or in part, to any persons to whom or into or within any jurisdiction where to do so would constitute a violation of applicable law or regulation.

The information contained herein and on the pages that follow does not constitute or form a part of any offer to sell or issue, or the solicitation of any offer to purchase, subscribe for or otherwise acquire, any securities in the United States or in any jurisdiction in which, or to any person to whom, such an offer or solicitation would be unlawful.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the “Investment Company Act”), and as such holders of the Shares are not and will not be entitled to the benefits of the Investment Company Act. The Shares have not been and will not be registered under the Securities Act, or with any securities regulatory authority of any state or other jurisdiction of the United States, and may not be offered, sold, resold, pledged, delivered, assigned or otherwise transferred, directly or indirectly, into or within the United States or to, or for the account or benefit of, any US Persons, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States and in a manner which would not result in the Company being required to register under the Investment Company Act. There has been and will be no public offer of the Shares in the United States. The offer and sale of the Shares have not been and will not be registered under the applicable securities laws of Australia, Canada, Japan or South Africa. Potential users of the information contained herein and on the pages that follow are requested to inform themselves about and to observe all applicable restrictions.

The information contained herein and on the pages that follow may contain forward-looking statements. Any statement other than a statement of historical fact is a forward-looking statement. Actual results may differ materially from those expressed or implied by any forward-looking statement. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. You should not place undue reliance on any forward-looking statement, which speaks only as of the date of its issuance. The Company may change these terms and conditions from time to time and any such changes will be posted on this website. Your access to this website is governed by the version of these terms and conditions then in force.

By clicking “Agree” below, you represent, warrant, undertake and agree that (1) you have read, understood and agree to be bound by the terms and conditions and other information set out herein, (2) you are permitted under applicable laws and regulations to receive the information contained herein and on the pages that follow, (3) you are either (a) located outside the United States and are not a US Person or (b) an existing shareholder of the Company who is a “qualified purchaser” as defined under the Investment Company Act and (4) you will not further transmit or send any information contained in this website to any other persons in the United States, to US Persons, or to any publications with a general circulation in the United States. If you cannot so represent, warrant, undertake and agree, you must click the button labelled “Decline” or otherwise exit this website.